Replies to post #28887 on Marker Therapeutics Inc (MRKR)

[rwwest]

Sounds like they are still using the expensive genetic work that Marker is designed to avoid. Whatever may be the effectiveness and side effect profile they may achieve, if it's still basically genetically complex and expensive Car-T, they would be at a great cost disadvantage when marketed.